Liz Barr
Overview
Explore the profile of Liz Barr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
172
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li J, Melberg M, Kittilson A, Abdel-Mohsen M, Li Y, Aga E, et al.
JCI Insight
. 2024 Feb;
9(3).
PMID: 38329130
BACKGROUNDIdentifying factors that predict the timing of HIV rebound after treatment interruption will be crucial for designing and evaluating interventions for HIV remission.METHODSWe performed a broad evaluation of viral and...
2.
Dube K, Eskaf S, Barr L, Palm D, Hogg E, Simoni J, et al.
AIDS Res Hum Retroviruses
. 2022 Mar;
38(6):510-517.
PMID: 35323030
The AIDS Clinical Trials Group A5345 study (NCT03001128) included an intensively monitored antiretroviral pause (IMAP), during which participants living with HIV temporarily stopped antiretroviral treatment (ART) in an effort to...
3.
Li J, Aga E, Bosch R, Pilkinton M, Kroon E, MacLaren L, et al.
Clin Infect Dis
. 2021 Jun;
74(5):865-870.
PMID: 34117753
Background: Development of human immunodeficiency virus (HIV) remission strategies requires precise information on time to HIV rebound after treatment interruption, but there is uncertainty regarding whether modern antiretroviral therapy (ART)...
4.
Diepstra K, Barr L, Palm D, Hogg E, Mollan K, Henley L, et al.
AIDS Res Hum Retroviruses
. 2021 Jan;
37(6):489-501.
PMID: 33472545
The AIDS Clinical Trials Group (ACTG) A5345 study included an intensively monitored antiretroviral pause (IMAP), during which a cohort of participants temporarily stopped antiretroviral treatment during chronic HIV infection. We...
5.
Barr L, Jefferys R
J Virus Erad
. 2020 Dec;
6(4):100010.
PMID: 33294212
Objectives: In 2018, we surveyed investigators conducting HIV cure-related clinical research, drawing on information from the online listing established by Treatment Action Group (TAG). The purpose of the survey was...
6.
Dube K, Hosey L, Starr K, Barr L, Evans D, Hoffman E, et al.
AIDS Res Hum Retroviruses
. 2020 Mar;
36(4):268-282.
PMID: 32160755
Women remain underrepresented in HIV research. The AIDS Clinical Trials Group (ACTG) 5366 study was the first HIV cure-related trial conducted exclusively in women. Our multidisciplinary team integrated participant-centered reports...
7.
Barr L, Jefferys R
J Virus Erad
. 2019 Nov;
5(4):212-219.
PMID: 31754444
Objectives: The community-based organisation Treatment Action Group has established an online listing of HIV cure-related trials and observational studies derived from trial registries. Our objective was to use the listing...
8.
Dube K, Eskaf S, Evans D, Sauceda J, Saberi P, Brown B, et al.
AIDS Res Hum Retroviruses
. 2019 Oct;
36(4):324-348.
PMID: 31608651
There are two concurrent and novel major research pathways toward strategies for HIV control: (1) long-acting antiretroviral therapy (ART) formulations and (2) research aimed at conferring sustained ART-free HIV remission,...
9.
Newton L, Necochea R, Palm D, Taylor J, Barr L, Patel H, et al.
J Virus Erad
. 2019 Jun;
5(2):122-124.
PMID: 31191916
The literature on HIV therapeutics research is rife with terminology associating 'sterilisation' with HIV cure. We find connotations of the word 'sterilising' problematic for the HIV cure research field. In...
10.
Dube K, Barr L, Palm D, Brown B, Taylor J
Lancet HIV
. 2019 Feb;
6(3):e147-e149.
PMID: 30772419
No abstract available.